BEACON TRANSCRIPT – Tthe FDA has recently approved a smart pill that is able to keep track of a person’s drug intake. The smart pill is going to be used for people who suffer from mental health disorders like acute manic depression and schizophrenia. It is designed to show if the patient took the drugs that were prescribed for his or her illness.
The Smart Pill and its Abilities and Controversies
This pill can’t be used for an emergency detection because its response time might suffer delays. Despite this, doctors will now be able to find out if their patients took the medicine they described them. This smart pill was named Abilify MyCite. The pill makes use of a tracking system to show the patient’s drug intake.
“Being able to track ingestion of medications prescribed for mental illness may be useful for some patients,” said Mitchell Mathis, the director of Psychiatry products at the FDA.
The system is integrated within aripiprazole tablets. When a person ingests this pill, a sensor from it transmits the information to a smartphone. A patch needs to be worn by the patient in order for the pill to work. Patients who have the app and the patch can also share their data with their doctors on a portal. This smart pill needs to be taken once a day to show the drug intake of a patient.
There are also some problems with the smart pill, one of them quite significant. Despite the fact that this pill can be used voluntarily for now, in the future this might become an invasion of privacy. The pill’s intake records could transmit a lot of personal information, one that hackers might be able to access. Medical insurance companies might also spy on their clients, suggest some.
The FDA mentioned that it supports the development of this new technology and that it wants to work with companies to learn more and continue developing it.
Image Source: MaxPixel